Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban ...

Indoco Remedies Ltd., a fully integrated, research-oriented pharmaceutical company, announced final approval of the company’s Abbreviated New Drug Application (ANDA) for rivaroxaban tablets USP, 2.5 ...

WASHINGTON, DC (updated with commentary) — In patients with venous thromboembolism (VTE) who had completed 6 to 12 months of anticoagulation therapy but for whom it was uncertain as to whether ...

In everyday practice, patients with atrial fibrillation or flutter who are newly started on apixaban (Eliquis; Bristol-Myers Squibb) have lower ischemic and bleeding risks compared with those started ...

Grenoble, France - With the long-awaited advents of rivaroxaban (Xarelto, Bayer/Johnson & Johnson), apixaban (Eliquis, Pfizer/Bristol-Myers Squibb), and dabigatran (Pradaxa, Boehringer Ingelheim) as ...

ORLANDO, FL—In emergency cases when rapid anticoagulation reversal is needed to prevent or stop major bleed events, a ‘decoy protein’ is showing potential to become the default antidote to undo the ...

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...